Poroma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07301424	Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL	not yet recruiting	Phase 2	80	University of AlbertaOTHER	1	Aug 12, 2026	clinicaltrials
NCT01221376	Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)	unknown	Phase 2	20	Renato MelaragnoOTHER	1	Mar 26, 2013	clinicaltrials
NCT01222013	Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)	suspended	Phase 2	20	Renato MelaragnoOTHER	0	Mar 26, 2013	clinicaltrials

Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials